| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $415.0M | -6.8% |
| Cost of Revenue | $209.5M | -8.0% |
| Gross Profit | $205.5M | -5.6% |
| R&D Expense | $600K | -45.5% |
| SG&A Expense | $130.0M | +2.0% |
| Operating Income | $75.5M | -16.4% |
| Pre-tax Income | $16.0M | -75.5% |
| Income Tax | $4.8M | -65.5% |
| Net Income | $11.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.4M | -17.1% |
| Accounts Receivable | $8.4M | +29.0% |
| Inventory | $119.9M | +36.9% |
| Current Assets | $257.7M | +3.4% |
| Total Assets | $572.1M | -4.9% |
| Current Liabilities | $41.4M | +2.6% |
| Long-term Debt | $406.8M | -1.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $30.3M | -55.6% |
| Capital Expenditures | $7.7M | +24.8% |
| Investing Cash Flow | -$18.8M | +68.1% |
| Financing Cash Flow | -$43.3M | -175.9% |
| Free Cash Flow | $22.6M | -63.6% |
| -77.6% |
| EPS (Basic) | $0.65 | -76.4% |
| EPS (Diluted) | $0.64 | -74.6% |
| Total Liabilities |
| $458.7M |
| -1.9% |
| Stockholders' Equity | $113.4M | -15.2% |